Pharmaceutical Marketing - Time for Change

dc.contributor.author	Buckley, Joan
dc.date.accessioned	2010-10-04T05:51:58Z
dc.date.available	2010-10-04T05:51:58Z
dc.date.issued	2004
dc.identifier.citation	Buckley, J. (2004). Pharmaceutical Marketing - Time for Change. EJBO - Electronic Journal of Business Ethics and Organization Studies, Vol. 9 (2). Retrieved from http://ejbo.jyu.fi
dc.identifier.uri	https://jyx.jyu.fi/handle/123456789/25358
dc.description.abstract	This paper reviews current marketing practices in the pharmaceutical sector, and their impact on consumer and doctor behaviour. It identifies negative impacts which include misleading advertising, disease mongering and escalating costs. It argues the need to move from industry self-regulation to an independently monitored code of practice for pharmaceutical marketing.	en
dc.language.iso	eng
dc.publisher	Business and Organization Ethics Network (BON)
dc.relation.ispartofseries	EJBO - Electronic Journal of Business Ethics and Organization Studies
dc.relation.uri	http://ejbo.jyu.fi
dc.rights	In Copyright
dc.title	Pharmaceutical Marketing - Time for Change
dc.type	article
dc.identifier.urn	URN:NBN:fi:jyu-201010042872
dc.relation.issn	1239-2685
dc.relation.numberinseries	2
dc.relation.volume	9
dc.rights.copyright	© Business and Organization Ethics Network (BON)
dc.rights.accesslevel	openAccess	fi
dc.rights.url	https://rightsstatements.org/page/InC/1.0/

Except where otherwise noted, this item's license is described as In Copyright

Related items